Central precocious puberty associated with duplicated pituitary: a case report and literature review
- PMID: 40007803
- PMCID: PMC11850256
- DOI: 10.3389/fendo.2025.1466411
Central precocious puberty associated with duplicated pituitary: a case report and literature review
Abstract
Patients with duplicated pituitary often have severe neurodevelopmental abnormalities and craniofacial deformities. Till now, only eight patients diagnosed with duplicated pituitary showing barely central precocious puberty (CPP) are reported in the published literature. Herein, we report a 6-year-old and 3-month-old girl diagnosed with pituitary duplication presented with CPP. She has enlarged breasts for more than 1 year, accelerated height of linear growth, advanced bone age, increased hormone level, and increased volume of uterus and ovary. A duplicated pituitary gland was shown in the MRI. As the gonadotropin-releasing hormone analogue (GnRHa) stimulation test showed a positive result, the child was treated with GnRHa. After 2 years of follow-up, there was a delay in the progression of sexual development, a reduction in symptoms of precocious puberty, and an increase in predicted adult height.
Keywords: GnRHa; central precocious puberty (CPP); duplicated pituitary; female; height.
Copyright © 2025 Yang, Sang, Dai and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.Endocr Rev. 1986 Feb;7(1):24-33. doi: 10.1210/edrv-7-1-24. Endocr Rev. 1986. PMID: 2937629 Review.
-
Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.J Clin Endocrinol Metab. 1999 Feb;84(2):449-52. doi: 10.1210/jcem.84.2.5431. J Clin Endocrinol Metab. 1999. PMID: 10022399 Clinical Trial.
-
Combined therapy with GnRH analog plus growth hormone in central precocious puberty.J Pediatr Endocrinol Metab. 2000 Jul;13 Suppl 1:811-20. doi: 10.1515/jpem.2000.13.s1.811. J Pediatr Endocrinol Metab. 2000. PMID: 10969926
-
Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis.Medicine (Baltimore). 2014 Dec;93(27):e260. doi: 10.1097/MD.0000000000000260. Medicine (Baltimore). 2014. PMID: 25501098 Free PMC article. Review.
-
Long-term effects and significant Adverse Drug Reactions (ADRs) associated with the use of Gonadotropin-Releasing Hormone analogs (GnRHa) for central precocious puberty: a brief review of literature.Acta Biomed. 2019 Sep 6;90(3):345-359. doi: 10.23750/abm.v90i3.8736. Acta Biomed. 2019. PMID: 31580327 Free PMC article. Review.
References
-
- Group of Endocrine and Genetic Metabolism. Chinese Academy of Pediatrics. Editorial Board of Chinese Journal of Pediatrics . Expert Consensus on the diagnosis and treatment of central precocious puberty(2022). Chin J Pediatr. (2023) 61:16–22. doi: 10.3760/cma.j.cn112140-20220802-00693 - DOI - PubMed
-
- de Penna GC, Pimenta MP, Drummond JB, Sarquis M, Martins JC, de Campos RC, et al. . Duplication of the hypophysis associated with precocious puberty: presentation of two cases and review of pituitary embryogenesis. Arg Bras Endocrinol Metabol. (2005) 49:323–7. doi: 10.1590/S0004-27302005000200023 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials